Resources library
Welcome to our resource library. We invite you to explore and view our extensive resources and information.
Addressing AAV Manufacturing Challenges
This brochure demonstrates how OXB addresses AAV manufacturing challenges with robust upstream, downstream, analyics and regulatory services.
View PDF >
How to De-risk Preclinical Lentiviral Manufacturing Ahead of IND
Practical guidance for teams translating promising lentiviral vectors into reproducible development programmes
View details >AAV: Novel Dual-Plasmid Transfection System
This brochure introduces OXB's novel dual plasmid transfection system for AAV development and manufacture.
View PDF >AAV: inAAVate™ Platform Infographic
This infographic explores the inAAVate™ platform and how it allows clients to accelerate their time to clinic.
View PDF >Improved Production and Quality of Lentiviral Vectors by Major-Splice-Donor Mutation and Co-expression of a Novel U1 snRNA-based Enhancer
Discover how the TetraVecta™ system eliminates aberrant vector RNA splicing, enhances TRiP system™ performance, and improves the safety and utility of next-generation gene therapy vectors.
View PDF >Enhanced Transcriptional Insulation of Lentiviral Vectors using “Sequence Upgraded polyA Long Terminal Repeats” or “supA-LTRs”
SupA-LTR technology enhances lentiviral vector safety and performance by reducing transcriptional read-through, improving polyadenylation, and increasing transgene expression.
View PDF >On-the-Fly Optimization of Anion-Exchange Chromatography for High-Purity AAV Separation
This poster is about OXB’s inAAVate™ platform for rapidly developing anion-exchange chromatography (AEX)-based purification processes that efficiently separate full and empty AAV capsids, achieving up to 90% full capsid purity while enabling faster, scalable gene therapy manufacturing workflows.
View PDF >